[1] |
TINGLE SJ, FIGUEIREDO RS, MOIR JA, et al. Hypothermic machine perfusion is superior to static cold storage in deceased donor kidney transplantation: a Meta-analysis[J]. Clin Transplant, 2020, 34(4): e13814. DOI: 10.1111/ctr.13814.
|
[2] |
JOCHMANS I, BRAT A, DAVIES L, et al. Oxygenated versus standard cold perfusion preservation in kidney transplantation (COMPARE): a randomised, double-blind, paired, phase 3 trial[J]. Lancet, 2020, 396(10263): 1653-1662. DOI: 10.1016/S0140-6736(20)32411-9.
|
[3] |
HENDRIKS KDW, BRÜGGENWIRTH IMA, MAASSEN H, et al. Renal temperature reduction progressively favors mitochondrial ROS production over respiration in hypothermic kidney preservation[J]. J Transl Med, 2019, 17(1): 265. DOI: 10.1186/s12967-019-2013-1.
|
[4] |
XU J, BUCHWALD JE, MARTINS PN. Review of current machine perfusion therapeutics for organ preservation[J]. Transplantation, 2020, 104(9): 1792-1803. DOI: 10.1097/TP.0000000000003295.
|
[5] |
HE X, CHEN G, ZHU Z, et al. The first case of ischemia-free kidney transplantation in humans[J]. Front Med (Lausanne), 2019, 6: 276. DOI: 10.3389/fmed.2019.00276.
|
[6] |
MINOR T, VON HORN C, GALLINAT A, et al. First-in-man controlled rewarming and normothermic perfusion with cell-free solution of a kidney prior to transplantation[J]. Am J Transplant, 2020, 20(4): 1192-1195. DOI: 10.1111/ajt.15647.
|
[7] |
HE X, JI F, ZHANG Z, et al. Combined liver-kidney perfusion enhances protective effects of normothermic perfusion on liver grafts from donation after cardiac death[J]. Liver Transpl, 2018, 24(1): 67-79. DOI: 10.1002/lt.24954.
|
[8] |
LI J, JIA J, HE N, et al. Combined kidney-liver perfusion enhances the proliferation effects of hypothermic perfusion on liver grafts via upregulation of IL-6/STAT3 signaling[J]. Mol Med Rep, 2019, 20(2): 1663-1671. DOI: 10.3892/mmr.2019.10379.
|
[9] |
ONISCU GC, RANDLE LV, MUIESAN P, et al. In situ normothermic regional perfusion for controlled donation after circulatory death--the United Kingdom experience[J]. Am J Transplant, 2014, 14(12): 2846-2854. DOI: 10.1111/ajt.12927.
|
[10] |
HOSGOOD SA, NICHOLSON ML. First in man renal transplantation after ex vivo normothermic perfusion[J]. Transplantation, 2011, 92(7): 735-738. DOI: 10.1097/TP.0b013e31822d4e04.
|
[11] |
NICHOLSON ML, HOSGOOD SA. Renal transplantation after ex vivo normothermic perfusion: the first clinical study[J]. Am J Transplant, 2013, 13(5): 1246-1252. DOI: 10.1111/ajt.12179.
|
[12] |
URBANELLIS P, HAMAR M, KATHS JM, et al. Normothermic ex vivo kidney perfusion improves early DCD graft function compared with hypothermic machine perfusion and static cold storage[J]. Transplantation, 2020, 104(5): 947-955. DOI: 10.1097/TP.0000000000003066.
|
[13] |
HOSGOOD SA, SAEB-PARSY K, WILSON C, et al. Protocol of a randomised controlled, open-label trial of ex vivo normothermic perfusion versus static cold storage in donation after circulatory death renal transplantation[J]. BMJ Open, 2017, 7(1): e012237. DOI: 10.1136/bmjopen-2016-012237.
|
[14] |
THOMPSON ER, CONNELLY C, ALI S, et al. Cell therapy during machine perfusion[J]. Transpl Int, 2021, 34(1): 49-58. DOI: 10.1111/tri.13780.
|
[15] |
HE X, GUO Z, ZHAO Q, et al. The first case of ischemia-free organ transplantation in humans: a proof of concept[J]. Am J Transplant, 2018, 18(3): 737-744. DOI: 10.1111/ajt.14583.
|
[16] |
O'NEILL S, SRINIVASA S, CALLAGHAN CJ, et al. Novel organ perfusion and preservation strategies in transplantation - where are we going in the United Kingdom?[J]. Transplantation, 2020, 104(9): 1813-1824. DOI: 10.1097/TP.0000000000003106.
|
[17] |
DE BEULE J, JOCHMANS I. Kidney perfusion as an organ quality assessment tool-are we counting our chickens before they have hatched?[J]. J Clin Med, 2020, 9(3): 879. DOI: 10.3390/jcm9030879.
|
[18] |
TCHOUTA LN, ALGHANEM F, ROJAS-PENA A, et al. Prolonged (≥24 hours) normothermic (≥32 ℃) ex vivo organ perfusion: lessons from the literature[J]. Transplantation, 2021, 105(5): 986-998. DOI: 10.1097/TP.0000000000003475.
|
[19] |
HAMEED AM, LU DB, PATRICK E, et al. Brief normothermic machine perfusion rejuvenates discarded human kidneys[J]. Transplant Direct, 2019, 5(11): e502. DOI: 10.1097/TXD.0000000000000944.
|
[20] |
ROZENBERG K, KNIJFF L, LOFARO L, et al. Normothermic machine perfusion of kidneys allows assessment of mitochondrial respiration and facilitates recovery following kidney injury[J]. Transpl Int, 2019, 32(S2): 157.
|
[21] |
FERDINAND JR, HOSGOOD SA, MOORE T, et al. Cytokine absorption during human kidney perfusion reduces delayed graft function-associated inflammatory gene signature[J]. Am J Transplant, 2021, 21(6): 2188-2199. DOI: 10.1111/ajt.16371.
|
[22] |
THOMPSON E, BATES L, IBRAHIM I, et al. Reconditioning marginal human kidneys using multistemtm cell therapy delivered during normothermic machine perfusion[J]. Transpl Int, 2019, 32(S2): 5-6.
|
[23] |
YUZEFOVYCH Y, VALDIVIA E, RONG S, et al. Genetic engineering of the kidney to permanently silence MHC transcripts during ex vivo organ perfusion[J]. Front Immunol, 2020, 11: 265. DOI: 10.3389/fimmu.2020.00265.
|
[24] |
TIETJEN GT, HOSGOOD SA, DIRITO J, et al. Nanoparticle targeting to the endothelium during normothermic machine perfusion of human kidneys[J]. Sci Transl Med, 2017, 9(418): eaam6764. DOI: 10.1126/scitranslmed.aam6764.
|
[25] |
HUANG Y, WANG J, JIANG K, et al. Improving kidney targeting: the influence of nanoparticle physicochemical properties on kidney interactions[J]. J Control Release, 2021, 334: 127-137. DOI: 10.1016/j.jconrel.2021.04.016.
|
[26] |
HAMEED AM, LU DB, BURNS H, et al. Pharmacologic targeting of renal ischemia-reperfusion injury using a normothermic machine perfusion platform[J]. Sci Rep, 2020, 10(1): 6930. DOI: 10.1038/s41598-020-63687-0.
|
[27] |
FRANZIN R, STASI A, FIORENTINO M, et al. Renal delivery of pharmacologic agents during machine perfusion to prevent ischaemia-reperfusion injury: from murine model to clinical trials[J]. Front Immunol, 2021, 12: 673562. DOI: 10.3389/fimmu.2021.673562.
|
[28] |
DIRITO JR, HOSGOOD SA, RESCHKE M, et al. Lysis of cold-storage-induced microvascular obstructions for ex vivo revitalization of marginal human kidneys[J]. Am J Transplant, 2021, 21(1): 161-173. DOI: 10.1111/ajt.16148.
|